<DOC>
	<DOCNO>NCT00180843</DOCNO>
	<brief_summary>Subjects undergo history , examination , lung function assessment inform consent obtain . All subject undergo ventilation-perfusion scan . If first scan normal undergo second final scan four week later . If abnormal undergo two scan either nebulized bronchodilator nebulized saline prior second third scan . Each time repeat lung function test prior scan . We examine regional change ventilation perfusion relationship lung function .</brief_summary>
	<brief_title>Assessment Ventilation-perfusion Abnormalities Patients With Stable Smoking-related Airways Disease</brief_title>
	<detailed_description>As Brief description</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>FEV1 &lt; 70 % predict baseline spirometry significant smoke history alpha 1 antitrypsin deficiency evidence current infection restrictive lung disease history significant respiratory disease significant respiratory infection within 6 week history significant physical mental illness render unfit study opinion investigator take part research within past 12 month , receive exposure ionize radiation</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>